Life Healthcare Group Holdings Limited provided earnings guidance for the year ending 30 September 2018. The Group has performed well overall with revenue expected to grow by between 10.0% and 14.0% compared to the year ended 30 September 2017 (prior year) and normalized EBITDA growing between 8.0% and 10.0%. Revenue expected to be ZAR 22,877 million to ZAR 23,709 million. Normalized EBITDA expected to be ZAR 5,401 million to ZAR 5,501 million. The company's share of net loss after tax for the year ended 30 September 2018 is expected to be between ZAR 115 million and ZAR 135 million (2017: ZAR 27 million).